Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Carcinoma, Non-Small-Cell Lung 5Lung Neoplasms 4Breast Neoplasms 4Breast Neoplasms, Male 3Sarcoma 2Prostatic Neoplasms 2Neoplasm Metastasis 2Kidney Neoplasms 2Central Nervous System Neoplasms 2Carcinoma, Renal Cell 2Carcinoma, Hepatocellular 2Brain Neoplasms 2Squamous Cell Carcinoma of Head and Neck 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Osteosarcoma 1Oligodendroglioma 1Neuroectodermal Tumors, Primitive, Peripheral 1Neoplasms, Plasma Cell 1Neoplasms 1Myelodysplastic Syndromes 1Multiple Myeloma 1Mesothelioma, Malignant 1Melanoma 1Liver Neoplasms 1Liposarcoma 1Leukemia 1Hepatitis C 1Head and Neck Neoplasms 1Gliosarcoma 1

Interventions

Ribavirin 4ledipasvir, sofosbuvir drug combination 2Sofosbuvir 2telaprevir 1pembrolizumab 1peginterferon alfa-2a 1grazoprevir 1elbasvir-grazoprevir drug combination 1elbasvir 1Rapid Diagnostic Tests 1Immunoenzyme Techniques 1Hypothermia, Induced 1Enzyme-Linked Immunosorbent Assay 1Chromatography, High Pressure Liquid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Has results × Hepatitis C × Immunoenzyme Techniques × Clear all
NCT00513461 2018-08-10

Liver Cancer Prevention Trial in Patients With Chronic Hep C Infection

University of California, Irvine

Phase 2 Completed
110 enrolled 21 charts
Gastrointestinal

Hepatitis C, Carcinoma, Hepatocellular

Data powered by HemOnc (CC BY 4.0) Colophon âš¡